Johnson and Johnson to acquire Joint Medical Products:
This article was originally published in Clinica
Johnson & Johnson has signed a definitive agreement to purchase hip and knee prosthesis company Joint Medical Products. Subject to clearance under the Hart-Scott-Rodino Act, the transaction is expected to close within 120 days.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.